46th Annual ASA Conference has gone Virtual
April 24-27, 2021

Abstract Submission is NOW OPEN!
DEADLINE: Wednesday, January 6, 2021 at 5:00pm ET (10:00pm GMT)

  • ASA only accepts electronic abstract submissions via the official abstract submission website.
  • Content should not be presented at another national meeting prior to the ASA Meeting nor be published prior to the abstract submission deadline.
  • A person cannot be the presenting author on more than two abstracts but can be co-author on any number of abstracts. 
  • ASA membership is not required for abstract submission.

Abstract Deadline Dates

Abstract submission

January 6, 2021

Abstract review by Program Committee

January 22, 2021

Program Committee and Awards Committee select abstract for oral presentation during meeting

February 5, 2021

Announcement of accepted abstracts and those competing for abstract awards

February 10, 2021

Abstract Guidelines

  • Word Count limit is 375 words or less excluding title and authors.
  • ONE uploaded image is allowed. Only PNG, TIFF, JPG.
  • Abstracts must be submitted with 4 components: introduction and objectives, methods, results, and conclusions.
  • Financial funding from commercial entities that have an interest in the research must be listed in the disclosure portion of the submission (in the Author section).
  • Oral and Poster presentation types will be offered. Your presentation will be given every consideration; however, the final determination will be made by the Program Committee.
  • The following submission categories will be offered, you will need to select the one that best fits your abstract: Androgens/Endocrinology, Environment/Toxicology, Epididymis/Vas Deferens/Seminal Vesicles, Fertilization/Germ Cell Differentiation/Reproductive Development Genetics, Infertility/Assisted Reproductive Technology/Male Contraception, Male Genital Reconstruction, Male Sexual Dysfunction, Prostate/Testis Cancer/Clinical Urology, Semen Transmission Viruses, Sperm Function/Semen Analysis, Spermatogenesis/Steroidogenesis/Testis Biology, Transgender Issues
  • No reference should be made in the abstract to the names or institutions of the authors.
  • Disclosures for ALL authors/co-authors is required within the submission form as well as their institutions, city, state, country, etc.
  • All accepted abstracts will be published as a supplement in Andrology, the official journal of the American Society of Andrology and the European Academy of Andrology.
  • Announcements of accepted and rejected submissions is planned for mid-February 2021.